Image
  China controls the rare earths the world buys - can Trump's new deals change that? US President Donald Trump has signed a flurry of deals on his Asia visit to secure the supply of rare earths, a critical sector that China has long dominated. The deals with Japan, Malaysia, Thailand, Vietnam and Cambodia differ in size and substance and it's too early to assess their tangible impact. But they all include efforts to diversify access to the minerals that have become essential for advanced manufacturing, from electric vehicles to smartphones. The agreements, which aim to lock partners into trading with the US, are a clear bid to reduce dependence on China, ahead of a key meeting with its leader Xi Jinping. They could eventually challenge Beijing's stranglehold over rare earths, but experts say it will be a costly process that will take years. "Building new mines, refining facilities, and processing plants in regions such as Australia, the United States, and Europe comes ...

Theranos founder Elizabeth Holmes loses fraud appeal


Theranos founder and former chief executive Elizabeth Holmes has lost an appeal against her conviction for defrauding investors in her blood-testing company.

Holmes was sentenced to more than 11 years in prison.

In her appeal, she challenged trial evidence and testimony and argued that statements by her ex-business and romantic partner Ramesh "Sunny" Balwani about his level of responsibility for Theranos' financial model should have been included. He was jailed for more than 12 years.

The Ninth Circuit Court of Appeals rejected the arguments.

Judge Jacqueline H Nguyen wrote that Theranos's claim of being able to run blood tests with a drop from a finger prick instead of a needle in a vein was "nothing more than a mirage".

"The grandiose achievements touted by Holmes and Balwani were half-truths and outright lies," Nguyen wrote in the opinion on behalf of a three-judge panel published on Monday.

Holmes was convicted in 2022 of conspiracy and multiple charges of wire fraud for misleading investors over the company's financial health and the effectiveness of its technology.

Balwani, who was tried separately and additionally convicted of defrauding patients in 2022, also lost his appeal.

In the appeal, both challenged a court order to pay $452m (£358m) in restitution to victims, which the court upheld.

In Holmes's appeal, she argued that statements from Balwani where he said he "owned" the company's financial model should have been included in the trial.

The appeal also argued that former Theranos employees offered improper expert testimony and a government inspection report should not have been included as evidence - all arguments the court dismissed.

Silicon Valley start-up Theranos was once valued at $9bn (£7bn).

But in late 2015, news reporting revealed internal struggles at the company and exposed the limitations of its technology. After a two-and-a-half-year investigation, a grand jury indicted Holmes and Balwani, leading to their convictions and sentencings.

Holmes entered prison in Texas in 2023.

Comments

Popular posts from this blog